BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/26/2024 8:53:40 AM | Browse: 136 | Download: 762
 |
Received |
|
2024-01-25 21:32 |
 |
Peer-Review Started |
|
2024-01-25 21:32 |
 |
First Decision by Editorial Office Director |
|
2024-02-01 21:53 |
 |
Return for Revision |
|
2024-02-01 21:53 |
 |
Revised |
|
2024-02-21 11:59 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-03-28 06:50 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-03-28 08:48 |
 |
Articles in Press |
|
2024-03-28 08:48 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-21 08:54 |
 |
Publish the Manuscript Online |
|
2024-04-26 08:53 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Chitin-glucan improves important pathophysiological features of irritable bowel syndrome
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Caroline Valibouze, Caroline Dubuquoy, Philippe Chavatte, Michaël Genin, Veronique Maquet, Salvatore Modica, Pierre Desreumaux and Christel Rousseaux |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Service Public de Wallonie (SPW-EER, convention 8588, Belgium) |
|
|
| Corresponding Author |
Christel Rousseaux, PhD, Researcher, Intestinal Biotech Development, Faculté de Médicine, Pole Recherche Amphi JK, Bd du Pr Jules Leclercq, Lille 59045, France. crousseaux@ibd-biotech.com |
| Key Words |
Chitin-glucan; Irritable bowel syndrome; Abdominal pain; Inflammation; Intestinal barrier; Molecular modelling; Microbial cell walls chelation |
| Core Tip |
Currently available irritable bowel syndrome (IBS) treatments are often inadequate. Chitin-glucan is a novel, well-tolerated, non-digestible prebiotic considered a safe food ingredient by the European Food Safety Authority. This study suggests new capacities of chitin-glucan to target most pathophysiological mechanisms of IBS and its therapeutic potential as a promising new generation of prebiotics for patients with IBS or IBS-like symptoms. |
| Publish Date |
2024-04-26 08:53 |
| Citation |
Valibouze C, Dubuquoy C, Chavatte P, Genin M, Maquet V, Modica S, Desreumaux P, Rousseaux C. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome. World J Gastroenterol 2024; 30(16): 2258-2271 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i16/2258.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i16.2258 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345